K-ras mutations in the bile of patients with primary sclerosing cholangitis

Gut

Volumn 48, Issue 3, 2001, Pages 403-408

  Kubicka, S ^a   Kuhnel F ^a   Flemming, P ^a   Hain, B ^a   Kezmic, N ^a   Rudolph, K L ^a   Manns, M ^a   Meier, P N ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cholangiocarcinogenesis; K ras mutations; Molecular diagnosis

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; BILE; BILE DUCT CARCINOMA; CANCER RISK; CONTROLLED STUDY; DYSPLASIA; FOLLOW UP; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

ADULT; BILE; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CASE-CONTROL STUDIES; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; GENES, RAS; GENETIC MARKERS; HUMANS; MIDDLE AGED; MUTATION; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0035056486     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.48.3.403     Document Type: Article

References (41)

1. Primary sclerosing cholangitis: Review of its clinical features, cholangiography and hepatic histology
2. Clinicopathologic features of the syndrome of primary sclerosing cholangitis
3. Primary sclerosing cholangitis
4. Primary sclerosing cholangitis: Natural history and prognostic factors, and survival analysis
5. Natural history and prognostic factors in 305 Swedish patients with PSC
6. Natural history and prognostic variables in primary sclerosing cholangitis
7. Orthotopic liver transplantation for primary sclerosing cholangitis
8. The first 100 liver transplantations at the Mayo Clinic
9. Efficacy of liver transplantation in patients with primary biliary cirrhosis
10. Primary sclerosing cholangitis: The emerging role for liver transplantation
11. Primary sclerosing cholangitis: Refinement and validation of survival models
12. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis
13. The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis
14. Primary sclerosing cholangitis: A long-term follow up study
15. Cholangiocarcinoma complicating primary sclerosing cholangitis
16. Cholangiocarcinoma complicating primary sclerosing cholangitis
17. Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential
18. Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation
19. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before liver transplantation
20. Biliary malignancies in primary sclerosing cholangitis: Timing for liver transplantation
21. Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis
22. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: A case control study
23. A genetic model for colorectal tumourigenesis
24. K-ras gene mutation in gall bladder carcinomas and dysplasia
25. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma
26. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia
27. Analysis of ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer
28. Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses
29. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice
30. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: Diagnostic utility and prognostic significance
31. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique
32. Point mutation of K-ras gene codon 12 in biliary tract tumours
33. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis
34. Biliary tract carcinoma complicating primary sclerosing cholangitis: Evaluation with CT, cholangiography, US, and MR imaging
35. Serum tumour markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis
36. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography
37. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice
38. The risk of pancreatic cancer following pancreatitis: An association due to confounding?
39. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience
40. Is liver transplantation indicated for cholangiocarcinoma?
41. Liver transplantation in a 29-year-old patient with gallbladder carcinoma complicating primary sclerosing cholangitis